Associations between remnant cholesterol levels and mortality in patients with diabetes

Table 4 Sensitivity analysis of remnant cholesterol and all-cause and cardiovascular mortality after excluding patients who died within 1 year of follow-up

	Hazard ratio (95%CI)
	Q1	Q2	Q3	Q4	Per SD	P value
All-cause mortality
Model 1	Reference	0.95 (0.72-1.24)	0.70 (0.54-0.92)	0.95 (0.74-1.21)	1.04 (0.97-1.12)	0.04
Model 2	Reference	0.89 (0.69-1.14)	0.72 (0.56-0.93)	0.98 (0.76-1.25)	1.11 (1.02-1.20)	< 0.01
Model 3	Reference	0.88 (0.69-1.13)	0.72 (0.56-0.92)	0.99 (0.77-1.26)	1.11 (1.02-1.21)	< 0.01
Model 4	Reference	0.88 (0.69-1.12)	0.70 (0.54-0.91)	0.97 (0.76-1.25)	1.10 (1.01-1.20)	< 0.01
Cardiovascular mortality
Model 1	Reference	1.30 (0.81-2.09)	0.65 (0.39-1.07)	0.96 (0.62-1.49)	1.04 (0.91-1.19)	0.05
Model 2	Reference	1.19 (0.76-1.87)	0.66 (0.41-1.07)	0.98 (0.64-1.51)	1.12 (0.97-1.29)	< 0.01
Model 3	Reference	1.20 (0.77-1.88)	0.67 (0.42-1.08)	0.98 (0.64-1.50)	1.11 (0.97-1.28)	< 0.01
Model 4	Reference	1.21 (0.77-1.90)	0.69 (0.43-1.13)	0.98 (0.64-1.52)	1.10 (0.96-1.26)	< 0.01

Model 1: No adjustment; Model 2: Adjusted for age, gender, ethnicity, body mass index (BMI), poverty-income ratio, education, survey period; Model 3: Adjusted for age, gender, ethnicity, BMI, poverty-income ratio, education, smoking status, alcohol consumption, survey period; Model 4: Adjusted for age, gender, ethnicity, BMI, poverty-income ratio, education, smoking status, alcohol consumption, survey period, hypercholesterolemia, hypertension, heart failure, coronary heart disease, and cancer.